Literature DB >> 20231323

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.

Avshalom Caspi1, Ahmad R Hariri, Andrew Holmes, Rudolf Uher, Terrie E Moffitt.   

Abstract

Evidence of marked variability in response among people exposed to the same environmental risk implies that individual differences in genetic susceptibility might be at work. The study of such Gene-by-Environment (GxE) interactions has gained momentum. In this article, the authors review research about one of the most extensive areas of inquiry: variation in the promoter region of the serotonin transporter gene (SLC6A4; also known as 5-HTT) and its contribution to stress sensitivity. Research in this area has both advanced basic science and generated broader lessons for studying complex diseases and traits. The authors evaluate four lines of evidence about the 5-HTT stress-sensitivity hypothesis: 1) observational studies about the serotonin transporter linked polymorphic region (5-HTTLPR), stress sensitivity, and depression in humans; 2) experimental neuroscience studies about the 5-HTTLPR and biological phenotypes relevant to the human stress response; 3) studies of 5-HTT variation and stress sensitivity in nonhuman primates; and 4) studies of stress sensitivity and genetically engineered 5-HTT mutations in rodents. The authors then dispel some misconceptions and offer recommendations for GxE research. The authors discuss how GxE interaction hypotheses can be tested with large and small samples, how GxE research can be carried out before as well as after replicated gene discovery, the uses of GxE research as a tool for gene discovery, the importance of construct validation in evaluating GxE research, and the contribution of GxE research to the public understanding of genetic science.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231323      PMCID: PMC2943341          DOI: 10.1176/appi.ajp.2010.09101452

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  154 in total

1.  Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk.

Authors:  K K Nicodemus; S Marenco; A J Batten; R Vakkalanka; M F Egan; R E Straub; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-01-15       Impact factor: 15.992

2.  Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene.

Authors:  Karani S Vimaleswaran; Shengxu Li; Jing Hua Zhao; Jian'an Luan; Sheila A Bingham; Kay-Tee Khaw; Ulf Ekelund; Nicholas J Wareham; Ruth J F Loos
Journal:  Am J Clin Nutr       Date:  2009-06-24       Impact factor: 7.045

Review 3.  Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain, and behavior.

Authors:  Sarah M Brown; Ahmad R Hariri
Journal:  Cogn Affect Behav Neurosci       Date:  2006-03       Impact factor: 3.282

4.  Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.

Authors:  Tina B Lonsdorf; Almut I Weike; Pernilla Nikamo; Martin Schalling; Alfons O Hamm; Arne Ohman
Journal:  Psychol Sci       Date:  2009-01-23

5.  An obesity-associated FTO gene variant and increased energy intake in children.

Authors:  Joanne E Cecil; Roger Tavendale; Peter Watt; Marion M Hetherington; Colin N A Palmer
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

6.  A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.

Authors:  Sean P David; Naga Venkatesha Murthy; Eugenii A Rabiner; Marcus R Munafó; Elaine C Johnstone; Robyn Jacob; Robert T Walton; Paul M Grasby
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

7.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

8.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Physical activity and the association of common FTO gene variants with body mass index and obesity.

Authors:  Evadnie Rampersaud; Braxton D Mitchell; Toni I Pollin; Mao Fu; Haiqing Shen; Jeffery R O'Connell; Julie L Ducharme; Scott Hines; Paul Sack; Rosalie Naglieri; Alan R Shuldiner; Soren Snitker
Journal:  Arch Intern Med       Date:  2008-09-08

Review 10.  Strategy for investigating interactions between measured genes and measured environments.

Authors:  Terrie E Moffitt; Avshalom Caspi; Michael Rutter
Journal:  Arch Gen Psychiatry       Date:  2005-05
View more
  464 in total

1.  Serotonin transporter genotype moderates the link between children's reports of overprotective parenting and their behavioral inhibition.

Authors:  Katie L Burkhouse; Brandon E Gibb; Meredith E Coles; Valerie S Knopik; John E McGeary
Journal:  J Abnorm Child Psychol       Date:  2011-08

2.  Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search.

Authors:  Rudolf Uher
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-12-10       Impact factor: 4.328

3.  Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice.

Authors:  Q Yu; C M Teixeira; D Mahadevia; Y Huang; D Balsam; J J Mann; J A Gingrich; M S Ansorge
Journal:  Mol Psychiatry       Date:  2014-03-04       Impact factor: 15.992

4.  Antidepressant effects on serotonin 1A/1B receptors in the rat brain using a gene x environment model.

Authors:  Stal Saurav Shrestha; Daniel S Pine; David A Luckenbaugh; Katarina Varnäs; Ioline D Henter; Robert B Innis; Aleksander A Mathé; Per Svenningsson
Journal:  Neurosci Lett       Date:  2013-11-25       Impact factor: 3.046

5.  Relationships among independent major depressions, alcohol use, and other substance use and related problems over 30 years in 397 families.

Authors:  Marc A Schuckit; Tom L Smith; Jelger Kalmijn
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

6.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

7.  A BRIEF INTRODUCTION TO THE NEUROGENETICS OF COGNITION-EMOTION INTERACTIONS.

Authors:  Matthew A Scult; Ahmad R Hariri
Journal:  Curr Opin Behav Sci       Date:  2017-10-15

8.  [Serotonin transporter gene and stress reactivity in unipolar depression. Role of the HPA system as endophenotype of the SLC6A4 gene].

Authors:  H Welper; A Aller; V Guttenthaler; S Höfels; L Lennertz; U Pfeiffer; S G Schwab; A Zobel
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

9.  Maternal prenatal smoking and offspring emotional problems: no moderating effect of maternal or child 5-HTTLPR genotype.

Authors:  Lot M Geels; Maria M Groen-Blokhuis; Catharina E M van Beijsterveldt; Jacqueline M Vink; Christel M Middeldorp; Meike Bartels; Kelly A Nelson; Patricia E Huizenga; Gareth E Davies; Dorret I Boomsma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-10-22       Impact factor: 3.568

10.  Reduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studies.

Authors:  Teresa M Karrer; Casey L McLaughlin; Carmela P Guaglianone; Gregory R Samanez-Larkin
Journal:  Neurobiol Aging       Date:  2019-04-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.